vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是COMPASS MINERALS INTERNATIONAL INC的1.4倍（$540.7M vs $396.1M），COMPASS MINERALS INTERNATIONAL INC净利率更高（4.7% vs -2.9%，领先7.6%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-59.8M），过去两年COMPASS MINERALS INTERNATIONAL INC的营收复合增速更高（4.3% vs -2.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
CMP vs ICUI — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $540.7M |
| 净利润 | $18.6M | $-15.7M |
| 毛利率 | 16.0% | 37.5% |
| 营业利润率 | 9.2% | 1.0% |
| 净利率 | 4.7% | -2.9% |
| 营收同比 | 28.9% | -14.1% |
| 净利润同比 | 178.8% | 34.0% |
| 每股收益（稀释后） | $0.43 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $396.1M | $540.7M | ||
| Q3 25 | $227.5M | $537.0M | ||
| Q2 25 | $214.6M | $548.9M | ||
| Q1 25 | $494.6M | $604.7M | ||
| Q4 24 | $307.2M | $629.8M | ||
| Q3 24 | $208.8M | $589.1M | ||
| Q2 24 | $202.9M | $596.5M | ||
| Q1 24 | $364.0M | $566.7M |
| Q4 25 | $18.6M | $-15.7M | ||
| Q3 25 | $-7.2M | $-3.4M | ||
| Q2 25 | $-17.0M | $35.3M | ||
| Q1 25 | $-32.0M | $-15.5M | ||
| Q4 24 | $-23.6M | $-23.8M | ||
| Q3 24 | $-48.3M | $-33.0M | ||
| Q2 24 | $-43.6M | $-21.4M | ||
| Q1 24 | $-38.9M | $-39.5M |
| Q4 25 | 16.0% | 37.5% | ||
| Q3 25 | 16.9% | 37.4% | ||
| Q2 25 | 19.2% | 37.9% | ||
| Q1 25 | 15.5% | 34.7% | ||
| Q4 24 | 11.2% | 36.1% | ||
| Q3 24 | 9.3% | 34.8% | ||
| Q2 24 | 16.1% | 34.8% | ||
| Q1 24 | 19.7% | 32.7% |
| Q4 25 | 9.2% | 1.0% | ||
| Q3 25 | 5.3% | 2.6% | ||
| Q2 25 | 7.4% | 1.9% | ||
| Q1 25 | -0.6% | 2.1% | ||
| Q4 24 | 0.2% | 6.0% | ||
| Q3 24 | -14.3% | 1.4% | ||
| Q2 24 | 2.9% | 1.3% | ||
| Q1 24 | -10.8% | -1.9% |
| Q4 25 | 4.7% | -2.9% | ||
| Q3 25 | -3.2% | -0.6% | ||
| Q2 25 | -7.9% | 6.4% | ||
| Q1 25 | -6.5% | -2.6% | ||
| Q4 24 | -7.7% | -3.8% | ||
| Q3 24 | -23.1% | -5.6% | ||
| Q2 24 | -21.5% | -3.6% | ||
| Q1 24 | -10.7% | -7.0% |
| Q4 25 | $0.43 | $-0.63 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | $-0.41 | $1.43 | ||
| Q1 25 | $-0.77 | $-0.63 | ||
| Q4 24 | $-0.57 | $-0.97 | ||
| Q3 24 | $-1.17 | $-1.35 | ||
| Q2 24 | $-1.05 | $-0.88 | ||
| Q1 24 | $-0.94 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | — |
| 总债务越低越好 | $890.0M | — |
| 股东权益账面价值 | $260.5M | $2.1B |
| 总资产 | $1.5B | $4.1B |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
| Q4 25 | $46.7M | — | ||
| Q3 25 | $59.7M | — | ||
| Q2 25 | $79.4M | — | ||
| Q1 25 | $49.5M | — | ||
| Q4 24 | $45.8M | $308.6M | ||
| Q3 24 | $20.2M | $312.5M | ||
| Q2 24 | $12.8M | $302.6M | ||
| Q1 24 | $38.3M | $251.4M |
| Q4 25 | $890.0M | — | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | — | ||
| Q1 25 | $807.6M | — | ||
| Q4 24 | $974.4M | — | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
| Q4 25 | $260.5M | $2.1B | ||
| Q3 25 | $234.1M | $2.1B | ||
| Q2 25 | $249.8M | $2.1B | ||
| Q1 25 | $236.5M | $2.0B | ||
| Q4 24 | $263.0M | $2.0B | ||
| Q3 24 | $316.6M | $2.0B | ||
| Q2 24 | $352.1M | $2.0B | ||
| Q1 24 | $400.4M | $2.1B |
| Q4 25 | $1.5B | $4.1B | ||
| Q3 25 | $1.5B | $4.1B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.5B | $4.2B | ||
| Q4 24 | $1.7B | $4.2B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.6B | $4.3B | ||
| Q1 24 | $1.7B | $4.3B |
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 3.41× | — | ||
| Q4 24 | 3.70× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $36.0M |
| 自由现金流率自由现金流/营收 | -15.1% | 6.6% |
| 资本支出强度资本支出/营收 | 5.8% | 4.6% |
| 现金转化率经营现金流/净利润 | -1.99× | — |
| 过去12个月自由现金流最近4个季度 | $94.1M | $91.8M |
8季度趋势，按日历期对齐
| Q4 25 | $-37.0M | $60.6M | ||
| Q3 25 | $-6.9M | $56.7M | ||
| Q2 25 | $21.8M | $11.2M | ||
| Q1 25 | $186.9M | $51.3M | ||
| Q4 24 | $-4.1M | $40.2M | ||
| Q3 24 | $-12.7M | $36.1M | ||
| Q2 24 | $-6.8M | $82.0M | ||
| Q1 24 | $86.2M | $45.8M |
| Q4 25 | $-59.8M | $36.0M | ||
| Q3 25 | $-22.8M | $27.6M | ||
| Q2 25 | $3.8M | $-8.5M | ||
| Q1 25 | $172.9M | $36.7M | ||
| Q4 24 | $-25.9M | $16.1M | ||
| Q3 24 | $-33.6M | $16.2M | ||
| Q2 24 | $-21.5M | $62.5M | ||
| Q1 24 | $56.2M | $29.9M |
| Q4 25 | -15.1% | 6.6% | ||
| Q3 25 | -10.0% | 5.1% | ||
| Q2 25 | 1.8% | -1.5% | ||
| Q1 25 | 35.0% | 6.1% | ||
| Q4 24 | -8.4% | 2.6% | ||
| Q3 24 | -16.1% | 2.7% | ||
| Q2 24 | -10.6% | 10.5% | ||
| Q1 24 | 15.4% | 5.3% |
| Q4 25 | 5.8% | 4.6% | ||
| Q3 25 | 7.0% | 5.4% | ||
| Q2 25 | 8.4% | 3.6% | ||
| Q1 25 | 2.8% | 2.4% | ||
| Q4 24 | 7.1% | 3.8% | ||
| Q3 24 | 10.0% | 3.4% | ||
| Q2 24 | 7.2% | 3.3% | ||
| Q1 24 | 8.2% | 2.8% |
| Q4 25 | -1.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
